Opus Genetics, Inc. (IRD) — Financial Flexibility Index
Opus Genetics, Inc. (IRD) has a Financial Flexibility Index of -0.28x as of December 2025. Free cash flow of $-9.83 Million (operating CF $-9.83 Million minus capex $0.00) represents 0% of total liabilities ($34.90 Million). Also explore Opus Genetics, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Opus Genetics, Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Opus Genetics, Inc. across 7 annual periods. Check IRD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Opus Genetics, Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for Opus Genetics, Inc.. For the full company profile including market capitalisation, see Opus Genetics, Inc. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | $-35.25 Million | $-35.25 Million | $34.90 Million | ▼ -19.0% |
| 2024 | -0.85x | $-25.58 Million | $-25.58 Million | $30.14 Million | ▼ -208.5% |
| 2023 | -0.28x | $-1.11 Million | $-1.11 Million | $4.04 Million | ▼ -105.3% |
| 2022 | 5.20x | $14.31 Million | $14.31 Million | $2.75 Million | ▲ +203.5% |
| 2021 | -5.02x | $-19.37 Million | $-19.37 Million | $3.85 Million | ▼ -2202.7% |
| 2020 | -0.22x | $-6.80 Million | $-6.80 Million | $31.15 Million | ▲ +42.9% |
| 2019 | -0.38x | $-3.57 Million | $-3.59 Million | $9.34 Million | — |